{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T02:05:15Z","timestamp":1774922715511,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG1 EY020522"],"award-info":[{"award-number":["UG1 EY020522"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ajo.2023.06.011","type":"journal-article","created":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T10:50:56Z","timestamp":1686999056000},"page":"xii-xiv","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Extensively Multi-drug\u2212Resistant Pseudomonas aeruginosa in Artificial Tears: Public Health Sleuthing Success but Challenges Ahead"],"prefix":"10.1016","volume":"253","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9350-5478","authenticated-orcid":false,"given":"Irene C.","family":"Kuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2023.06.011_bib0001","article-title":"Outbreak of extensively drug-resistant Pseudomonas aeruginosa associated with artificial tears","year":"2023","journal-title":"Accessed"},{"issue":"8","key":"10.1016\/j.ajo.2023.06.011_bib0002","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1080\/14787210.2022.2071701","article-title":"Treatment of carbapenem-resistant Pseudomonas aeruginosa infections: a case for cefiderocol","volume":"20","author":"Canton","year":"2022","journal-title":"Expert Rev Anti-infect Ther"},{"key":"10.1016\/j.ajo.2023.06.011_bib0003","unstructured":"Stobbe M, Associated Press. How officials cracked case of eyedrops that blinded people: \u2018A public health victory\u2019. 2023. Accessed May 27, 2023. https:\/\/fortune.com\/well\/2023\/02\/28\/public-health-officials-crack-case-eyedrops-blind-death-cdc-fda-antibiotic-resistant-bacteria\/."},{"key":"10.1016\/j.ajo.2023.06.011_bib0004","unstructured":"American Academy of Ophthalmology. Update: multistate cluster of VIM- and GES-producing carbapenem-resistant Pseudomonas aeruginosa associated with artificial tears. Accessed May 27, 2023. https:\/\/www.aao.org\/Assets\/3a187c94-7889-42e8-84a1-6b2e88e7d374\/638098403609770000\/epix-multistate-pseudomonas-investigation-20jan2023-pdf?inline=1."},{"key":"10.1016\/j.ajo.2023.06.011_bib0005","unstructured":"Centers for Disease Control and Prevention. Emergency Preparedness and Response. Distributed by CDC Health Network. Outbreak of extensively drug-resistant Pseudomonas aeruginosa associated with artificial tears. 2023. Accessed May 27, 2023. https:\/\/emergency.cdc.gov\/han\/2023\/han00485.asp."},{"key":"10.1016\/j.ajo.2023.06.011_bib0006","unstructured":"Centers for Disease Control and Prevention. 2019 Antibiotic resistance threats report. 2021. Accessed May 27, 2023. https:\/\/www.cdc.gov\/drugresistance\/biggest-threats.html."},{"key":"10.1016\/j.ajo.2023.06.011_bib0007","unstructured":"Tacconelli E, Magrini N. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. World Health Organization. Accessed May 27, 2023. http:\/\/remed.org\/wp-content\/uploads\/2017\/03\/lobal-priority-list-of-antibiotic-resistant-bacteria-2017.pdf."},{"key":"10.1016\/j.ajo.2023.06.011_bib0008","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00277-23","article-title":"Investigating and treating a corneal ulcer due to extensively drug-resistant Pseudomonas aeruginosa","author":"Morelli","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajo.2023.06.011_bib0009","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13756-019-0556-9","article-title":"Mortality related to Verona integron-encoded metallo-beta-lactamase-positive Pseudomonas aeruginosa: assessment by a novel clinical tool","volume":"8","author":"Persoon","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.ajo.2023.06.011_bib0010","unstructured":"US Government Accountability Office. Drug Safety: FDA should take additional steps to improve its foreign inspection program. 2022. Accessed May 27, 2023. https:\/\/www.gao.gov\/products\/gao-22-103611."},{"key":"10.1016\/j.ajo.2023.06.011_bib0011","article-title":"After pandemic delays, FDA still struggling to inspect foreign drug manufacturers","author":"Hwang","year":"2023","journal-title":"Propublica"},{"key":"10.1016\/j.ajo.2023.06.011_bib0012","unstructured":"US Food and Drug Administration. FDA warns consumers not to purchase or use EzriCare Artificial Tears due to potential contamination. 2023. Accessed May 27, 2023. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-warns-consumers-not-purchase-or-use-ezricare-artificial-tears-due-potential-contamination."},{"key":"10.1016\/j.ajo.2023.06.011_bib0013","unstructured":"US Food and Drug Administration. Safeguarding pharmaceutical supply chains in a global economy. 2019. Accessed May 27, 2023. https:\/\/www.fda.gov\/news-events\/congressional-testimony\/safeguarding-pharmaceutical-supply-chains-global-economy-10302019."},{"key":"10.1016\/j.ajo.2023.06.011_bib0014","unstructured":"US Government Accounting Ofiice. Drug safety: preliminary findings indicate persistent challenges with FDA foreign inspections. 2019. Accessed May 27, 2023. https:\/\/www.gao.gov\/products\/gao-20-262t."},{"key":"10.1016\/j.ajo.2023.06.011_bib0015","doi-asserted-by":"crossref","DOI":"10.1097\/ICL.0000000000000993","article-title":"Corneal culture and antibiotic susceptibility results for microbial keratitis in the Mid-Atlantic region of the United States, 2016-2020","author":"Shekhawat","year":"2023","journal-title":"Eye Contact Lens"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423002428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423002428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:55:13Z","timestamp":1757598913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939423002428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":15,"alternative-id":["S0002939423002428"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2023.06.011","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extensively Multi-drug\u2212Resistant Pseudomonas aeruginosa in Artificial Tears: Public Health Sleuthing Success but Challenges Ahead","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2023.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}